Brind.

Akiko Iwasaki, a professor at Yale, joined the SPEAR Study Group, which is led by Invivyd using monoclonal antibody technology.

1 report, 1 independent Updated Jul 23

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Yale

Keep exploring

The entities involved

Yale
Canadian political candidate
- A Yale-led study has emerged focusing on various agricultural practices across the United States.Thu 17:08
- Grade inflation is reported to degrade the value of academic credentials.Thu 08:15

Coverage

Newest first; wire copies grouped

Jul 23GlobeNewswireScientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome WALTHAM, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Invivy